ALEMBIC
Back to Income Statement
|
ALEMBIC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹222 Cr | ₹157 Cr | ₹127 Cr | ₹78 Cr | ₹74 Cr |
What is the latest Revenue of ALEMBIC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹222 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹127 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹74 Cr |
How is Revenue of ALEMBIC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹222 Cr | 40.89 | |
| Mar2024 | ₹157 Cr | 23.77 | |
| Mar2023 | ₹127 Cr | 62.68 | |
| Mar2022 | ₹78 Cr | 6.40 | |
| Mar2021 | ₹74 Cr | - | |
Compare Revenue of peers of ALEMBIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC | ₹2,092.7 Cr | -6.3% | -16.9% | -15.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,782.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,125.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,252.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,025.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹102,443.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
ALEMBIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC | -6.3% |
-16.9% |
-15.3% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses